Xenotransplantation continues to present daunting scientific hurdles but there is now a genuine prospect for clinical application. There are also significant and unknown risks. We call for a moratorium on all human xenotransplantation and offer a strategy for balancing the ethical, medical, scientific and societal demands of xenotransplantation prior to human clinical trials.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
What does it take to consent to islet cell xenotransplantation?: Insights from an interview study with type 1 diabetes patients and review of the literature
BMC Medical Ethics Open Access 01 April 2021
-
Islet Xeno/transplantation and the risk of contagion: local responses from Canada and Australia to an emerging global technoscience
Life Sciences, Society and Policy Open Access 23 October 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bach, F.H., Turman, M.A., Vercellotti, G.M., Platt, J.L., & Dalmasso, A.P. Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplantation Proceedings 23, 205–207 (1991).
Bach, F.H., Winkler, H., Ferran, C., Hancock, W.W., & Robson, S.C. Delayed xenograft rejection. Immunology Today 17, 379–384 (1996).
Bach, F.H., et al. Accommodation of vascularized xenografts: expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environment. Nature Medicine 3, 196–204 (1997).
Cooper, D.K., et al. Specific intravenous carbohydrate therapy. A new concept in inhibiting antibody-mediated rejection—experience with ABO-incompatible cardiac allografting in the baboon. Transplantation 56, 769–777 (1993).
Dalmasso, A.P., Vercellotti, G.M., Platt, J.L., & Bach, F.H. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 52, 530–533 (1991).
Dalmasso, A.J., & Bach, F.H. Expression of human regulators of complement activation on pig endothelial cells. Xeno 4, 55–57 (1996).
Sachs, D.H., Sykes, M., Greenstein, J.L., & Cosimi, A.B. Tolerance and Xenograft Survival. Nature Medicine 1, 969 (1995).
Platt, J.L. . Xenotransplantation: recent progress and current perspectives. Current Opinion in Immunology 8, 721–728 (1996).
Deacon, T. . et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nature Med. 3, 350–353 (1997).
Animal Tissue to Humans: A Report of the Advisory Group on the Ethics of Xenotransplantation, London (1996).
Animal-to-Human Transplants: The Ethics of Xenotransplantation., London, (1996).
Draft Public Health Service Guideline in Infectious Disease Issues in Xenotransplantation, (1996).
Xenotransplantation: Science, Ethics and Public Policy. Institute of Medicine, Washington, D.C. (1996).
Understanding Risk: Informing Decisions in a Democratic Society (eds. Stern, P.C., and Fineberg, H.V.) Washington, D.C. (1996).
Berg, P., Baltimore, D., Brenner, S., Roblin, R.O., & Singer, M.F. Summary statement of the Asilomar conference on recombinant DNA molecules. Proceedings of the National Academy of Sciences of the United States of America 72, 1981–1984 (1975).
Berg, P., Baltimore, D., Brenner, S., Roblin, R.O.r., and Singer, M.F. Asilomar conference on recombinant DNA molecules. Science 188, 991–994 (1975).
Fishman, J.A. . Miniature swine as organ donors for man: Strategies for prevention of xenotransplant-associated infections. Xenotransplantation 1, 47–57 (1994).
Fishman, J.A. . Xenosis and xenotransplantation: addressing the infectious risks posed by an emerging technology. Kidney International - Supplement 58, S41–S45 (1997).
Chapman, L.E. . et al. Xenotransplantation and xenogeneic infections. N.E.M. 333, 1498–1501 (1995).
Patience, C., Takeuchi, Y., & Weiss, R.A. Infection of human cells by an endogenous retrovirus of pigs [see comments]. Nature Med. 3, 282–286 (1997).
Daar, A.S. Ethic of Xenotransplantation - Animal Issues, Consent, and Likely Transformation of Transplant Ethics. World J. Surgery 21 (9), 975–982 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bach, F., Fishman, J., Daniels, N. et al. Uncertainty in xenotransplantation: Individual benefit versus collective risk. Nat Med 4, 141–144 (1998). https://doi.org/10.1038/nm0298-141
Issue Date:
DOI: https://doi.org/10.1038/nm0298-141
This article is cited by
-
Cardiac Xenotransplantation: a New Frontier for Advanced Heart Failure
Current Treatment Options in Cardiovascular Medicine (2023)
-
What does it take to consent to islet cell xenotransplantation?: Insights from an interview study with type 1 diabetes patients and review of the literature
BMC Medical Ethics (2021)
-
Islet Xeno/transplantation and the risk of contagion: local responses from Canada and Australia to an emerging global technoscience
Life Sciences, Society and Policy (2015)